News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
We show, for the first time, that diabetes may interfere with the activity of immunotherapy – Ido Wolf
Photo from Ido Wolf/Linkedin
Jun 25, 2023, 17:37

We show, for the first time, that diabetes may interfere with the activity of immunotherapy – Ido Wolf

So proud, an extremely important observation of our group.
We show, for the first time, that diabetes may interfere with the activity of immunotherapy.
If validated by other groups as well, it may be practice changing.

For details – Click here

 

Source:

#cancer patients acsjournals cancer diabetes Ido Wolf immunotherapy OncoDaily Oncology
Special Coverage
Insight
Jan 15, 2025, 18:32
MD Anderson Study Reveals Integrated Care as Top Strategy for Smoking Cessation in Lung Screening
Insight
Jan 15, 2025, 18:31
Mehdi Hamadani: Current status of ADCs in lymphoma DLBCL
Blog
Jan 15, 2025, 18:25
Discussion on advancing the Global Cancer Fund at The White House - ASCO
Blog
Jan 15, 2025, 18:19
Antonio Passaro: COCOON study meets primary endpoint
Blog
Jan 15, 2025, 17:58
Felice Gorordo: The White House's round table on the creation of the Global Cancer Fund
Insight
Jan 15, 2025, 17:48
ESO announced the mentorship pairings for 2025
Insight
Jan 15, 2025, 17:38
Baris Turkbey: Impact of Endorectal Coil Use on Extraprostatic Extension Detection in Prostate MRI
Blog
Jan 15, 2025, 17:37
Shalini Rao: Delighted to chair the Gordon Research Seminar on Pancreatic Diseases in Maine
Blog
Jan 15, 2025, 17:33
Exploring the Future of HR+/HER2- MBC Treatment – Live Webinar by SPCC
Insight
Jan 15, 2025, 17:27
Integration of Generative AI into Radiation Therapy practice
Insight
Jan 15, 2025, 17:26
Ajay Major: Summary table of all studies of CAR-T in CNS lymphomas
Insight
Jan 15, 2025, 17:19
Yakup Ergün: A Perspective on the MARS2 Trial by Eric Lim et al